Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 22, 2003
Declining incidence of AIDS and increasing prevalence of AIDS presenters among AIDS patients in ItalyB Castelnuovo, E Chiesa, S Rusconi, et al.
Research in Developmental Disabilities|May 15, 2018
Developmental delay in communication among toddlers and its relationship to caregiving behavior among violence-exposed, posttraumatically stressed mothersR Torrisi, E Arnautovic, V C Pointet Perizzolo, et al.
Journal of Virology|September 12, 2000
Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection: in vitro studies of mixed virus infectionsS Rusconi, S La Seta Catamancio, P Citterio, et al.
BMC Infectious Diseases|June 7, 2017
Clinical and genetic factors associated with kidney tubular dysfunction in a real-life single centre cohort of HIV-positive patientsS E Salvaggio, A Giacomelli, F S Falvella, et al.
Blood|July 15, 1996
Human immunodeficiency virus (HIV) phenotype and interleukin-2/ interleukin-10 ratio are associated markers of protection and progression in HIV infectionM Clerici, C Balotta, A Salvaggio, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 10, 2001
Predictive role of the three-month CD4 cell count in the long-term clinical outcome of the first HAART regimenA d' Arminio Monforte, F Adorni, L Meroni, et al.
Antiviral Therapy|December 1, 1996
Viral load, viral phenotype modification, zidovudine susceptibility and reverse transcriptase mutations during the first 6 months of zidovudine monotherapy in HIV-1-infected peopleS Rusconi, M P De Pasquale, F Mainini, et al.
AIDS (London, England)|July 14, 2000
Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategyS Menzo, S Rusconi, A Monachetti, et al.
Clinical Immunology (Orlando, Fla.)|September 10, 1999
Altered signaling lymphocytic activation molecule (SLAM) expression in HIV infection and redirection of HIV-specific responses via SLAM triggeringL Meroni, M L Fusi, S Varchetta, et al.
AIDS Research and Human Retroviruses|July 17, 1999
Aminooxypentane-RANTES, an inhibitor of R5 human immunodeficiency virus type 1, increases the interferon gamma to interleukin 10 ratio without impairing cellular proliferationS Rusconi, S La Seta-Catamancio, S Kurtagic, et al.
Pageof 10